(This link opens in a new window) Cancel Click here to leave this site. Financial Highlights; Financial Data (Annual Data) Financial Data (Quarterly Data) Sales of Major Products ; Revenue by Region; Annual Report; IR Library. Track Astellas Pharma stock price in real-time ahead here. Royalty income makes up a small percentage of Astellas' overall sales. There is no recent news for this security. Investors. A high-level overview of Astellas Pharma Inc. (ALPMF) stock. Click here to access press releases from Astellas Pharma Inc. located in Tokyo, Japan. Latest Developments More. View the latest Astellas Pharma Inc. (ALPMF) stock price, news, historical charts, analyst ratings and financial information from WSJ. Earnings Momentum Score Average 47.79 Login to Access: 47.79 Login to Access: Dividend Quality Score Average 100 Login to Access: Login to Access: Fundamental Score Above Average 82 Login to Access: 29.00 Login to Access: Dividend Yield (%) Average 2.31 Login to Access: 1.16 Login to Access: Next release date The vast majority of the company's revenue is derived from Japanese markets, followed by the Americas. Company Participants. Astellas Pharma Inc. TEL +81-3-3244-3201 Release for the financial results of Astellas for FY2004 Japan, May 17, 2005 - Astellas Pharma Inc. today announced the financial results of former Yamanouchi Pharmaceutical Co., Ltd. and former Fujisawa Pharmaceutical Co., Ltd. for FY2004 (fiscal year ended March 31, 2005). News . Vesomni 6 mg/0.4 mg modified release tablets. Get the latest Astellas Pharma Inc. ALPMY detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Get today's Astellas Pharma Inc. stock price and latest 4503 news as well as Astellas Pharma Inc. real-time stock quotes, technical analysis, full financials and more. Earnings Date-Ex Div Date 09/25/2020; Div Amount 0.2011; Split Date-Split Factor-Latest Astellas Pharma Inc News. There is no recent news for this security. Astellas Pharma Inc. … The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. Company Participants. Earnings Date-Ex Div Date 09/29/2020; Div Amount 21.00; Split Date-Split Factor-Latest Astellas Pharma Inc News. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Astellas Pharma (ALPMY) reported 3rd Quarter December 2020 earnings of $0.31 per share on revenue of $3.1 billion.. Astellas Pharma Inc and its subsidiaries are engaged in manufacturing, marketing and import/export of pharmaceuticals. The Astellas Pharma Inc PE ratio based on its reported earnings over the past 12 months is 24.68.The shares are currently trading at ¥1849.5.. Thank you for visiting the Astellas Pharma Inc. Website. Earnings date: N/A: Forward dividend & yield: 0.36 (2.60%) Ex-dividend date: 30 Mar 2021: 1y target est: N/A: All. Astellas shares fell in afternoon trading after the earnings release, closing down 2% at 1,544 yen amid investor concern about a looming patent cliff. Astellas Pharma PE ratio as of February 02, 2021 is 18.94. Therapeutic Goods Administration AusPAR Betmiga mirabegron Astellas Pharma Australia Pty Ltd PM-2012-01928-3-3 Date of Finalisation 9 January 2014 Page 2 of 74 About the Therapeutic Goods Administration (TGA) • The Therapeutic Goods Administration (TGA) is part of the Australian Government Department of Health, and is responsible … TOKYO, March 11, 2021 - Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced the submission of a New Drug Application (NDA) to Japan's Ministry of Health, Labour and Welfare (MHLW) for enfortumab vedotin for the treatment of patients with locally advanced or metastatic urothelial cancer that has progressed after anti-cancer … Last Earnings Release: N/A; Next Ex-Dividend Date: N/A; Last Ex-Dividend Date: Sep. 28, 2020; Description: Astellas Pharma Inc is a drug manufacturing company that sells pharmaceutical products across the globe. (1) Consolidated financial results of Yamanouchi Pharmaceutical Co., … This is an estimated date of earnings release. OSI is now a wholly-owned subsidiary of Astellas US Holding, Inc., a holding company owned by Astellas Pharma Inc., and OSI's common stock has ceased to … Strategic Plan 2018; Financial Information. It is based on a 36-month historical regression of the return on the stock onto the return on the S&P 500. On August 4, Astellas Pharma will present their latest quarterly figures. Analysts on Wall Street predict Astellas Pharma will release earnings per share of ¥29.99. Astellas and Seagen Announce Presentation of Results from PADCEV® (enfortumab vedotin-ejfv) Pivotal Trial in Patients with Previously Treated Advanced Urothelial Cancer Who Were Ineligible for Cisplatin Chemotherapy. Last Earnings Release: N/A; Next Ex-Dividend Date: N/A; Last Ex-Dividend Date: Sep. 29, 2020; Description: Astellas Pharma Inc is a drug manufacturing company that sells pharmaceutical products across the globe. Analysts on Wall Street expect Astellas Pharma will release earnings per share of $0.308. Astellas Receives … Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). Astellas Pharma (ALPMY) Recent Earnings. Astellas Pharma Completes Acquisition Of Iota Biosciences. Diary of Japan (.N225) corporate earnings for the week ahead JAPAN EARNINGS Start Date Start RIC Company Name Event Name Time 11-May-2020 02:30 9107.T Kawasaki Kisen … Wall Street predict expect Astellas Pharma will release earnings per share of ¥22.35. Astellas Pharma Inc (OTCPK:ALPMF) Q1 2021 Earnings Conference Call August 4, 2020 3:00 AM ET. Astellas Pharma Inc (OTCPK:ALPMF) Q3 2021 Earnings Conference Call January 29, 2021 2:00 AM ET. You will enter external sites beyond here. ESSA Pharma Announces Clinical Collaboration with Astellas to Evaluate the Combination of EPI-7386 and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer Press releases. On May 14, Astellas Pharma is presenting Q4 earnings. Q3 2021 Astellas Pharma Inc Earnings Release. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. Naoki Okamura – Representative Director and Executive Vice President. There is no recent news for this security. Astellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries around the world. Earnings Date-Ex Div Date 09/29/2020; Div Amount 21.00; Split Date-Split Factor-Latest Astellas Pharma Inc News. Earnings: The amount and date of latest Earnings Per Share (EPS) paid out to shareholders. Wall Street analysts expect Astellas Pharma will release earnings per share of ¥30.25. Astellas Pharma reported 21.29 in PE Price to Earnings for its fourth fiscal quarter of 2020. Astellas Pharma Inc. (TSE: 4503) announced today that it had extended its all-cash tender offer for $57.50 per share for all of the currently outstanding shares of common stock (including the associated stock purchase rights) of OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) to 12:00 midnight New York City time on Wednesday, June 2, 2010, unless further extended. Royalty income makes up a small percentage of Astellas' overall sales. Active Ingredients: Solifenacin succinate, Tamsulosin Hydrochloride . On October 30, Astellas Pharma will release earnings for the most recent quarter. Astellas Pharma will report earnings from the last quarter on January 29. Get News Alerts by Email Year All Years 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 Category All Categories Corporate Corporate Awards Corporate Social Responsibility Our People Therapeutic Area News Uncategorized Keywords Go The latest earnings, revenues and financial reports for Astellas Pharma Inc. (4503). Sponsor: Astellas Pharma Australia Pty Ltd January 2014 . Company: Astellas Pharma Co. Ltd. EPS: The annual earnings per share. Replays of most recent earnings release conference calls; Calendar of events (including upcoming earnings conference call dates and times, as well as planned interaction with research analysts and institutional investors) Corporate Governance information; About Astellas . The vast majority of the company's revenue is derived from Japanese markets, followed by the Americas. PR Newswire.
Eines Tages Duden, Sallust Bellum Iugurthinum übersetzung, Distributivgesetz Aufgaben Pdf, Fiat Ducato Hochdach Wohnmobil, Knochenpräparation Handbuch Für Praktiker, Verlassene Dörfer In Der Eifel, Josef Guggenmos Sommerregen,